CS207455B2 - Method of preparation of the new therapeutic mixture - Google Patents
Method of preparation of the new therapeutic mixture Download PDFInfo
- Publication number
- CS207455B2 CS207455B2 CS773204A CS320477A CS207455B2 CS 207455 B2 CS207455 B2 CS 207455B2 CS 773204 A CS773204 A CS 773204A CS 320477 A CS320477 A CS 320477A CS 207455 B2 CS207455 B2 CS 207455B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- formula
- compounds
- polyvinylpyrrolidone
- hydroxy
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D519/02—Ergot alkaloids of the cyclic peptide type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19762621906 DE2621906A1 (de) | 1976-05-17 | 1976-05-17 | Neue therapeutische mischung und verfahren zu deren herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS207455B2 true CS207455B2 (en) | 1981-07-31 |
Family
ID=5978199
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS773204A CS207455B2 (en) | 1976-05-17 | 1977-05-16 | Method of preparation of the new therapeutic mixture |
Country Status (22)
| Country | Link |
|---|---|
| JP (1) | JPS52139730A (ko) |
| AT (1) | AT366574B (ko) |
| AU (1) | AU513718B2 (ko) |
| BE (1) | BE854694A (ko) |
| CA (1) | CA1088865A (ko) |
| CS (1) | CS207455B2 (ko) |
| DE (1) | DE2621906A1 (ko) |
| ES (1) | ES458819A1 (ko) |
| FR (1) | FR2351657A1 (ko) |
| GB (1) | GB1565447A (ko) |
| GR (1) | GR72995B (ko) |
| HK (1) | HK3283A (ko) |
| HU (1) | HU175167B (ko) |
| IE (1) | IE45197B1 (ko) |
| IL (1) | IL52101A (ko) |
| MY (1) | MY8400062A (ko) |
| NL (1) | NL177981C (ko) |
| NZ (1) | NZ184111A (ko) |
| PH (1) | PH20257A (ko) |
| PT (1) | PT66552B (ko) |
| SE (1) | SE425545B (ko) |
| ZA (1) | ZA772935B (ko) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2935515A1 (de) * | 1979-09-03 | 1981-03-19 | Fa. Dr. Willmar Schwabe, 7500 Karlsruhe | Arzneipraeparat |
| JPH0227013U (ko) * | 1988-08-10 | 1990-02-22 | ||
| MXPA01009658A (es) | 1999-03-26 | 2003-06-24 | Pozen Inc | Composiciones de dihidroergotamina de alta potencia. |
-
1976
- 1976-05-17 DE DE19762621906 patent/DE2621906A1/de active Granted
-
1977
- 1977-05-09 SE SE7705340A patent/SE425545B/xx not_active IP Right Cessation
- 1977-05-12 FR FR7714507A patent/FR2351657A1/fr active Granted
- 1977-05-13 PH PH19768A patent/PH20257A/en unknown
- 1977-05-13 GB GB20210/77A patent/GB1565447A/en not_active Expired
- 1977-05-13 NL NLAANVRAGE7705306,A patent/NL177981C/xx not_active IP Right Cessation
- 1977-05-16 CS CS773204A patent/CS207455B2/cs unknown
- 1977-05-16 PT PT66552A patent/PT66552B/pt unknown
- 1977-05-16 HU HU77SA3035A patent/HU175167B/hu not_active IP Right Cessation
- 1977-05-16 JP JP5624877A patent/JPS52139730A/ja active Granted
- 1977-05-16 AT AT0347677A patent/AT366574B/de not_active IP Right Cessation
- 1977-05-16 CA CA278,488A patent/CA1088865A/en not_active Expired
- 1977-05-16 IL IL52101A patent/IL52101A/xx unknown
- 1977-05-16 NZ NZ184111A patent/NZ184111A/xx unknown
- 1977-05-16 ES ES458819A patent/ES458819A1/es not_active Expired
- 1977-05-16 AU AU25169/77A patent/AU513718B2/en not_active Expired
- 1977-05-16 IE IE1001/77A patent/IE45197B1/en unknown
- 1977-05-16 BE BE177623A patent/BE854694A/xx not_active IP Right Cessation
- 1977-05-17 ZA ZA00772935A patent/ZA772935B/xx unknown
- 1977-05-17 GR GR53485A patent/GR72995B/el unknown
-
1983
- 1983-01-20 HK HK32/83A patent/HK3283A/xx unknown
-
1984
- 1984-12-30 MY MY62/84A patent/MY8400062A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPS628413B2 (ko) | 1987-02-23 |
| SE7705340L (sv) | 1977-11-18 |
| GR72995B (ko) | 1984-01-24 |
| IE45197L (en) | 1977-11-17 |
| PT66552A (en) | 1977-06-01 |
| CA1088865A (en) | 1980-11-04 |
| ATA347677A (de) | 1981-09-15 |
| ES458819A1 (es) | 1978-08-01 |
| GB1565447A (en) | 1980-04-23 |
| HU175167B (hu) | 1980-05-28 |
| DE2621906A1 (de) | 1977-12-01 |
| HK3283A (en) | 1983-01-20 |
| AU2516977A (en) | 1978-11-23 |
| NL177981C (nl) | 1986-01-02 |
| IL52101A (en) | 1980-01-31 |
| BE854694A (fr) | 1977-11-16 |
| IL52101A0 (en) | 1977-07-31 |
| NL7705306A (nl) | 1977-11-21 |
| MY8400062A (en) | 1984-12-31 |
| AU513718B2 (en) | 1980-12-18 |
| NZ184111A (en) | 1980-02-21 |
| NL177981B (nl) | 1985-08-01 |
| PH20257A (en) | 1986-11-14 |
| SE425545B (sv) | 1982-10-11 |
| AT366574B (de) | 1982-04-26 |
| ZA772935B (en) | 1979-01-31 |
| IE45197B1 (en) | 1982-07-14 |
| FR2351657B1 (ko) | 1980-01-18 |
| JPS52139730A (en) | 1977-11-21 |
| FR2351657A1 (fr) | 1977-12-16 |
| PT66552B (en) | 1979-09-03 |
| DE2621906C2 (ko) | 1988-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL217835B1 (pl) | Preparat farmaceutyczny zawierający sól wapniową atorwastatyny, sposób wytwarzania tego preparatu i jego zastosowanie do leczenia hipercholesterolemii i hiperlipidemii | |
| SK286562B6 (sk) | Kryštalická forma A omeprazolu, kompozícia a farmaceutický prípravok s jej obsahom, spôsob jej prípravy a jej použitie | |
| US4226861A (en) | N-Lower-alkyl 3-phenoxy-1-azetidinecarboxamides | |
| JPH07300417A (ja) | 抗うつまたは抗パーキンソン病薬 | |
| CS208661B2 (en) | Method of making the n-/2-phenyl-2-hydroxyethyl/-1,1-dimethyl-3-phenylpropylamin derivatives | |
| CZ20002392A3 (cs) | Léčivo pro léčbu obezity a farmaceutický prostředek k tomuto účelu | |
| CA2321369C (en) | Dosing regimens for lasofoxifene | |
| SK281193B6 (sk) | Tableta so zlepšenou biodostupnosťou účinnej látky, kyseliny klodrónovej, spôsob jej výroby a použitie mikrokryštalickej celulózy | |
| US7955620B2 (en) | Stable oral composition | |
| KR20140111044A (ko) | 구연산아일데나필 결정 형태 o 및 그의 제조방법과 용도 | |
| CS207455B2 (en) | Method of preparation of the new therapeutic mixture | |
| JP2002532429A (ja) | 薬学的処方物 | |
| CZ287563B6 (en) | Pharmaceutical preparations for treating hyperglycemia | |
| JPH1192369A (ja) | 医薬品調製物、その製造方法及びシランセトロンの安定化のための酸性添加剤の使用 | |
| EP1880992A1 (en) | Stable modifications of tegaserod hydrogen maleate | |
| SK11632003A3 (sk) | Stabilný farmaceutický prípravok obsahujúci modifikáciu II torsemidu | |
| MXPA02000033A (es) | Polimorfos de un diclorhidrato cristalino de azobiciclo (2, 2, 2)oct-3-ilamina y sus composiciones farmaceuticas. | |
| KR100476606B1 (ko) | 결정질 아자비시클로(2,2,2)옥탄-3-아민 시트레이트의다형체 및 그의 제약 조성물 | |
| US20050069584A1 (en) | Diphenhydramine tannate solid dose compositions and methods of use | |
| US3155584A (en) | Compositions and method of inhibiting monoamine oxidase and treating hypertension | |
| CS246078B2 (en) | Method of production of pyroxycame salts with base deposited on pharmaceutically accepted carrier | |
| US3993778A (en) | Anti-ulcerogenic pharmaceutical compositions containing a 2-amino-3,5-dibromo-benzylamine and method of use | |
| HU192050B (en) | Process for production of medical preparative containing co-dergocrin and one piridin-dicarbonic acid diesthertype calcium-antagonist | |
| US6784315B2 (en) | Stilbene derivative crystal and method for producing the same | |
| SK11695A3 (en) | Use of 3-benzoyl-3,7-diazobicyclo£3,3,1| nonane compounds as antiarhytmic effective medicament and method of its production |